Opioid use disorder and COVID-19: Implications for policy and practice

被引：6

作者：

Mitchell, Michaela ^{[1
]}

Shee, Kameron ^{[1
]}

Champlin, Kelly ^{[2
]}

Essary, Alison C. ^{[3
,4
]}

Evans, Matthew ^{[5
]}

机构：

[1] HonorHlth Acad Affairs, Scottsdale, AZ USA

[2] Midwestern Univ, Arizona Coll Osteopath Med, Downers Grove, IL 60515 USA

[3] HonorHlth Acad Affairs, Res Qual Improvement & Patient Safety program, Scottsdale, AZ USA

[4] No Arizona Univ, Coll Hlth Sci, Biomed Campus, Flagstaff, AZ 86011 USA

[5] HonorHlth Community Bridges Inc, Scottsdale, AZ USA

来源：

JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2021年 / 34卷 / 06期

关键词：

opioid use disorder; COVID-19; medications for addiction treatment; telehealth; regulatory; policy; DISPARITIES;

D O I：

10.1097/01.JAA.0000742976.14811.36

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Preliminary data suggest that opioid-related overdose deaths have increased subsequent to COVID-19. Despite national support for expanding the role of physician assistants (PAs) and NPs in serving patients with opioid use disorder, these clinicians are held to complex and stringent regulatory barriers. COVID-19 triggered significant changes from regulatory and federal agencies, yet disparate policies and regulations persist between physicians and PAs and NPs. The dual epidemics of COVID-19 and opioid use disorder highlight the inadequate infrastructure required to support patients, communities, and clinicians, and may serve as the catalyst for eliminating barriers to care.

引用

页码：1 / 4

页数：4

共 50 条

[21] Pharmacists and opioid use disorder care during COVID-19: Call for action
Mohammad, Insaf
Berri, Dena
Lehr, Victoria Tutag
JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2022, 5 (02): : 203 - 213
[22] COVID-19 vaccination coverage, vaccine hesitancy and opioid use disorder: Correspondence
Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj
DRUG AND ALCOHOL REVIEW, 2023, 42 (01) : 233 - 233
[23] Race, Trust, and COVID-19 Vaccine Hesitancy in People with Opioid Use Disorder
Sullivan, Matthew C.
Mistler, Colleen
Copenhaver, Michael M.
Wickersham, Jeffrey A.
Ni, Zhao
Kim, Rayne S.
Shrestha, Roman
HEALTH PSYCHOLOGY, 2022, 41 (02) : 115 - 120
[24] Leveraging COVID-19 to sustain regulatory flexibility in the treatment of opioid use disorder
Stringer, Kristi Lynn
Langdon, Kirsten J.
McKenzie, Michelle
Brockmann, Brad
Marotta, Phillip
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2021, 123
[25] Modernizing regulations for treating opioid use disorder during the COVID-19 pandemic
Iacono, Tara M.
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2022, 35 (02): : 57 - 59
[26] Substance use and homelessness: A longitudinal interview study conducted during COVID-19 with implications for policy and practice
Neale, Joanne
Parkin, Stephen
Hermann, Laura
Metrebian, Nicola
Roberts, Emmert
Robson, Deborah
Strang, John
INTERNATIONAL JOURNAL OF DRUG POLICY, 2022, 108
[27] Covid-19 and implications for future practice
Jull, Gwendolen
Moore, Ann P.
MUSCULOSKELETAL SCIENCE AND PRACTICE, 2022, 60
[28] An examination of telehealth policy impacts on initial rural opioid use disorder treatment patterns during the COVID-19 pandemic
Hughes, Phillip M.
Verrastro, Genevieve
Fusco, Carriedelle Wilson
Wilson, Courtenay Gilmore
Ostrach, Bayla
JOURNAL OF RURAL HEALTH, 2021, 37 (03): : 467 - 472
[29] Telemedicine Use and Quality of Opioid Use Disorder Treatment in the US During the COVID-19 Pandemic
Hailu, R.
Mehrotra, A.
Huskamp, H. A.
Busch, A. B.
Barnett, M. L.
JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2023, 26 : S12 - S13
[30] Telemedicine Use and Quality of Opioid Use Disorder Treatment in the US During the COVID-19 Pandemic
Hailu, Ruth
Mehrotra, Ateev
Huskamp, Haiden A.
Busch, Alisa B.
Barnett, Michael L.
JAMA NETWORK OPEN, 2023, 6 (01) : e2252381

← 1 2 3 4 5 →